Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Income from Continuing Operations (2020 - 2026)

Cresco Labs' (CRLBF) quarterly Income from Continuing Operations came in at 11426000.0 in Q1 2026, down 14.72% YoY from 13398000.0 in Q1 2025, and up 113.39% on a QoQ basis from 85341000.0 in Q4 2025.

Cresco Labs (CRLBF) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 7 years of Income from Continuing Operations data on file, last reported at 11426000.0 in Q1 2026.

  • Quarterly Income from Continuing Operations fell 14.72% year-over-year to 11426000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 52770000.0 (down 382.13% YoY) and the FY2025 annual result came in at 140044000.0, down 131.52% from the prior year.
  • Income from Continuing Operations advanced to 11426000.0 in Q1 2026, from 85341000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 38980000.0 in Q2 2022 to a low of 133101000.0 in Q4 2022.
  • A 5-year average of 8943176.47 and a median of 11426000.0 in 2026 frame the typical range for Income from Continuing Operations.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations surged 498.53% — and 2025, when it slumped 1604.87%.
  • Tracing CRLBF's Income from Continuing Operations over 5 years: stood at 133101000.0 in 2022, then surged by 115.6% to 20768000.0 in 2023, then slumped by 72.69% to 5671000.0 in 2024, then tumbled by 1604.87% to 85341000.0 in 2025, then jumped by 113.39% to 11426000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 11426000.0 (Q1 2026), 85341000.0 (Q4 2025), and 1766000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 43.76 Bn 42.79 Bn - -
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn 1.33 Bn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - -
10 Cresco Labs 291.27 Mn 227.16 Mn 86.95 Mn -22.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.43 Mn
Dec 31, 2025 -85.34 Mn
Sep 30, 2025 1.77 Mn
Jun 30, 2025 19.38 Mn
Mar 31, 2025 13.40 Mn
Dec 31, 2024 5.67 Mn
Sep 30, 2024 30.34 Mn
Jun 30, 2024 -30.70 Mn
Mar 31, 2024 33.95 Mn
Dec 31, 2023 20.77 Mn
Sep 30, 2023 -124.94 Mn
Jun 30, 2023 -15.59 Mn
Mar 31, 2023 5.81 Mn
Dec 31, 2022 -133.10 Mn
Sep 30, 2022 34.22 Mn
Jun 30, 2022 38.98 Mn
Mar 31, 2022 21.94 Mn
Dec 31, 2021 35.15 Mn
Sep 30, 2021 -219.60 Mn
Jun 30, 2021 29.58 Mn